Longaeva Partners »

Capricor Therapeutics shares owned by Longaeva Partners

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.8M 74k 24.08

More positions owned by Longaeva Partners

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Goldman Sachs Put Option (GS)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr St Str Care Etf Call Option (XLV)
Bank of America Corporation (BAC)
Pfizer Call Option (PFE)
Boston Scientific Corporation Call Option (BSX)
Fifth Third Ban (FITB)
Huntington Bancshares Incorporated (HBAN)
Moody's Corporation (MCO)
Mettler-Toledo International (MTD)
Lpl Financial Holdings (LPLA)
Us Bancorp Com New (USB)
Morgan Stanley Com New (MS)

View all positions for Longaeva Partners

Top funds holding Capricor Therapeutics

BlackRock
Tang Capital Management
Suvretta Capital Management
Vanguard Capital Management
State Street Corporation
Susquehanna International
Goldman Sachs Group
Citadel Advisors
RA Capital Management
Perceptive Advisors
Boxer Capital Management
Geode Capital Management
FMR
Ikarian Capital
Diadema Partners

View all funds holding Capricor Therapeutics